Sir Tommy Steele's incurable condition that lingers on from childhood - porphyria
The 1950s rock 'n' roller credits luck for his good health in older age. (Source: Daily Express - Health)
Source: Daily Express - Health - March 25, 2023 Category: Consumer Health News Source Type: news
Acute Hepatic Porphyrias Not as Rare as Previously Thought Acute Hepatic Porphyrias Not as Rare as Previously Thought
Recent treatment advances have improved the outlook for patients with acute hepatic porphyrias.MDedge News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 1, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Royal Family Affliction or Not, Porphyria Is Treatable Royal Family Affliction or Not, Porphyria Is Treatable
"If patients know they have the diagnosis, and they do the right things and avoid alcohol and risky drugs, most people will have few acute attacks."MDedge (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 19, 2022 Category: Gastroenterology Tags: Hematology-Oncology News Source Type: news
How Is Porphyria Diagnosed?
Title: How Is Porphyria Diagnosed?Category: Diseases and ConditionsCreated: 8/17/2021 12:00:00 AMLast Editorial Review: 8/17/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - August 17, 2021 Category: Cardiology Source Type: news
What Is In A Ketogenic Diet?
Discussion
Epilepsy is a common problem for the general pediatrician. Its incidence is estimated at 41-87/100,000 children. While many children are controlled with medication, it is also estimated that up to 1/3 will develop drug-resistant epilepsy. Some children may have an identifiable seizure focus that may be amenable to surgery, but many others do not. One option for potential control is a ketogenic diet (KD).
Indications for KD usually are for drug-resistant epilepsy including partial and complex seizure patterns as well as some metabolic disorders such as glucose transport 1 deficiency syndrome. It has also found ...
Source: PediatricEducation.org - September 7, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
What Causes Porphyria
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 7, 2020 Category: General Medicine Source Type: news
EMA Panel Backs First Treatment for Acute Hepatic Porphyria EMA Panel Backs First Treatment for Acute Hepatic Porphyria
The European Medicines Agency ' s Committee for Medicinal Products for Human Use recommended marketing authorization for the first treatment for acute hepatic porphyria.International Approvals (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 1, 2020 Category: Gastroenterology Tags: Gastroenterology News Alert Source Type: news
Drug Trials Snapshots: GIVLAARI
Drug for adults with acute hepatic porphyria (AHP). AHP is a rare metabolic disease resulting from a buildup of porphyrin molecules formed during the production of heme. AHP is characterized by acute attacks leading pain, paralysis, respiratory failure, seizures and mental changes. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 27, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Porphyria
Title: PorphyriaCategory: Diseases and ConditionsCreated: 3/5/2012 12:00:00 AMLast Editorial Review: 1/16/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - January 16, 2020 Category: Cardiology Source Type: news
Givlaari Approved for Acute Hepatic Porphyria
Title: Givlaari Approved for Acute Hepatic PorphyriaCategory: Health NewsCreated: 11/23/2019 12:00:00 AMLast Editorial Review: 11/25/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - November 25, 2019 Category: Cardiology Source Type: news
Givlaari Approved for Acute Hepatic Porphyria
FRIDAY, Nov. 22, 2019 -- On Wednesday, the U.S. Food and Drug Administration announced the approval of Givlaari (givosiran) for the treatment of acute hepatic porphyria.
Previous treatment options for this genetic disorder have only provided partial... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 22, 2019 Category: General Medicine Source Type: news
FDA Approves Givlaari (givosiran) for Acute Hepatic Porphyria
CAMBRIDGE, Mass.--(BUSINESS WIRE) November 20, 2019 --Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the U.S. Food and Drug Administration (FDA) approved Givlaari (givosiran) injection for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 20, 2019 Category: Drugs & Pharmacology Source Type: news
FDA approves givosiran for acute hepatic porphyria
Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - November 20, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA approves first treatment for inherited rare disease
Today, the U.S. Food and Drug Administration granted approval to Givlaari (givosiran) for the treatment of adult patients with acute hepatic porphyria, a genetic disorder resulting in the buildup of toxic porphyrin molecules which are formed during the production of heme (which helps bind oxygen in the blood). (Source: World Pharma News)
Source: World Pharma News - November 20, 2019 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news
New class of medicines shows promise
'Gene silencing' spares patients the crippling pain of intermittent porphyria Related items fromOnMedica Higher cancer risk from chronic diseases Hepatocellular carcinoma risk, cirrhosis and hepatitis C Kidney disease hits 850 million people Commonest genetic mutation causes much morbidity Prevention screening for one third of population (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 14, 2019 Category: UK Health Source Type: news
